Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels
Crossref DOI link: https://doi.org/10.1038/aps.2018.21
Published Online: 2018-05-10
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Hui-xian
Chen, Yang
Xu, Rong
He, Qi-yang
Text and Data Mining valid from 2018-05-10
Article History
Received: 30 October 2017
Accepted: 11 February 2018
First Online: 10 May 2018